Exploring safe practice when handling cytotoxic drugs: findings from survey of UK cancer nurses
Intended for healthcare professionals
Evidence and practice    

Exploring safe practice when handling cytotoxic drugs: findings from survey of UK cancer nurses

Karen Campbell Associate professor in cancer nursing, Edinburgh Napier University, Edinburgh, Scotland
Daniel Dicksit Research fellow, Edinburgh Napier University, Edinburgh, Scotland

Why you should read this article:
  • To refresh your knowledge of the risks posed by cytotoxic drugs

  • To understand the types of safety measures commonly used by nurses when administering cytotoxic drugs

  • To explore whether cancer nurses have an appropriate level of knowledge regarding safety measures such as personal protective equipment

Background Cytotoxic drugs, including chemotherapy, potentially pose significant risks to cancer nurses. Therefore, it is important to take measures to protect them from the health effects associated with these drugs.

Aim To determine UK cancer nurses’ perceptions and experiences regarding potential exposure to cytotoxic drugs, including their knowledge of hazards, use of personal protective equipment (PPE) and closed system transfer devices (CSTDs), and perceived health effects.

Method A cross-sectional survey was conducted across the UK, facilitated through the UK Oncology Nursing Society. Descriptive analyses were employed.

Results The survey revealed that the PPE predominantly used by respondents when administering cytotoxic drugs were plastic aprons (97%, n=723/747) and either gloves labelled for use with chemotherapy (62%, n=466/747) or other gloves (53%, n=393/747). Around 70% (n=521/747) of respondents had used CSTDs during administration. Perceived health effects associated with handling cytotoxic drugs were reported by 161 respondents.

Conclusion This study indicates that most cancer nurses have a high level of knowledge of the hazards of cytotoxic drugs, and that plastic aprons and gloves are the primary protection used against occupational exposure. However, there appear to be variation in their use of CSTDs. Many cancer nurses perceive their health to be compromised due to the handling of cytotoxic drugs. It is recommended that all cancer treatment settings across the UK should implement CSTDs.

Cancer Nursing Practice. doi: 10.7748/cnp.2025.e1878

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Correspondence

k.campbell@napier.ac.uk

Conflict of interest

None declared

Campbell K, Dicksit D (2025) Exploring safe practice when handling cytotoxic drugs: findings from a survey of UK cancer nurses. Cancer Nursing Practice. doi: 10.7748/cnp.2025.e1878

Acknowledgments

This study was funded by a UK Oncology Nursing Society grant. Thank you to Dr Martha Polovich for the use of the survey

Published online: 04 March 2025

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Are you a student? Our student subscription has content especially for you.
Find out more